Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study on the Efficacy of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive by Next Generation Flow

NCT03992170 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Senese as lead sponsor.

NCT NCT03992170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03992170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study on the Efficacy of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive by Next Generation Flow
Lead sponsor
Azienda Ospedaliera Universitaria Senese
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2018
Completion date
December 31, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma multiple